Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Director | March 13, 2023 | March 15, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date March 13, 2023 · Filed March 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,871 |
Reported balance
After 2023-03-13 transaction · row 1
1 source rowRow 1 · 2023-03-13 · Exercise / conversion · Acquired 10,000 · Balance 100,871 |
| Non-qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.30 · Expires 2023-05-23 | Direct | 0 |
Reported balance
After 2023-03-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-13 · Exercise / conversion · Acquired 10,000 · Balance 0 F2: These options were granted on May 23, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. |
| Common StockSEC Table I · non-derivative | IndirectHeld by spouse | 5,300 |
Reported balance
Holding disclosure · report date 2023-03-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,300 F1: The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F2: These options were granted on May 23, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2023 Filed Mar 15, 2023 17:07 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 10,000 | $9.30 Strike: $9.30 | $93,000.00 |
DisclosureSEC source: 0001323885-23-000035 · wf-form4_167891440770815.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Non-qualified Stock Option (right to buy) · 10,000 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 23, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 17:07 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $9.30 | $93,000.00 |
DisclosureSEC source: 0001323885-23-000035 · wf-form4_167891440770815.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 27, 2022 09:02 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 3,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-22-000072 · wf-form4_165365656472244.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,871 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 08:58 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 10,000 | $8.04 Strike: $8.04 | $80,400.00 |
DisclosureSEC source: 0001323885-22-000037 · wf-form4_164760829673834.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Non-qualified Stock Option (right to buy) · 10,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 15, 2012. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 08:58 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $8.40 | $84,000.00 |
DisclosureSEC source: 0001323885-22-000037 · wf-form4_164760829673834.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 08:12 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 4,000 | $80.91 | $323,640.00 |
DisclosureSEC source: 0001209191-21-063295 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,307 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $80.00 to $82.11 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 07:54 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 3,000 | $79.61 | $238,830.00 |
DisclosureSEC source: 0001209191-21-045220 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,307 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $79.19 to $80.18 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 20, 2021 Filed May 24, 2021 16:36 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035335 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,307 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 06, 2021 Filed May 10, 2021 08:18 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $14.17 | $0.00 |
DisclosureSEC source: 0001209191-21-031116 · doc4.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 18, 2011 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| May 06, 2021 Filed May 10, 2021 08:18 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $14.17 | $141,700.00 |
DisclosureSEC source: 0001209191-21-031116 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 08:07 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 3,000 | $65.28 | $195,840.00 |
DisclosureSEC source: 0001209191-21-024940 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,558 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $64.35 to $65.81 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 07:47 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 3,000 | $55.36 | $166,080.00 |
DisclosureSEC source: 0001209191-21-001761 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,558 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $54.72 to $55.78 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 08:39 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 2,330 | $40.00 | $93,200.00 |
DisclosureSEC source: 0001209191-20-054258 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,558 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.05 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 08:45 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 670 | $40.20 | $26,934.00 |
DisclosureSEC source: 0001209191-20-053445 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,888 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.08 to $40.36 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 08:21 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 4,000 | $44.60 | $178,400.00 |
DisclosureSEC source: 0001209191-20-040853 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,558 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $44.00 to $45.10 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 20, 2020 Filed May 22, 2020 08:11 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031550 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,558 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 12, 2020 Filed May 14, 2020 08:12 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0001209191-20-029027 · doc4.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 19, 2010 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| May 12, 2020 Filed May 14, 2020 08:12 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $5.15 | $51,500.00 |
DisclosureSEC source: 0001209191-20-029027 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 08:09 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 4,000 | $36.07 | $144,280.00 |
DisclosureSEC source: 0001209191-20-023995 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,106 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $36.00 to $36.23 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 07:38 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 4,000 | $35.02 | $140,080.00 |
DisclosureSEC source: 0001209191-20-003792 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,106 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.09 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 22, 2019 Filed May 24, 2019 08:51 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032580 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,106 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 07:03 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001209191-19-019579 · doc4.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 10,000 shares Expires 2019-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 21, 2009 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 07:03 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $2.58 | $25,800.00 |
DisclosureSEC source: 0001209191-19-019579 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 06:28 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 2,090 | $25.00 | $52,250.00 |
DisclosureSEC source: 0001209191-18-038220 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,898 F1 · price: The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 22, 2018 Filed May 24, 2018 16:27 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032975 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,988 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 08:02 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.31 | $0.00 |
DisclosureSEC source: 0001209191-18-004677 · doc4.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2018-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on February 6, 2008 and is exercisable cumulatively at a rate of 25% per annum beginning one year from date of grant. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 08:02 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 25,000 | $13.31 | $332,750.00 |
DisclosureSEC source: 0001209191-18-004677 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 16:19 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.31 | $0.00 |
DisclosureSEC source: 0001209191-17-053155 · doc4.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2018-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on February 6, 2008 and is exercisable cumulatively at a rate of 25% per annum beginning one year from date of grant. Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 16:19 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 25,000 | $13.31 | $332,750.00 |
DisclosureSEC source: 0001209191-17-053155 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 25, 2017 16:23 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035356 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,767 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.